For the Inventor, By the Inventor

Enter assignee name

Peabody, MA, United States of America

Progeria Research Foundation, Inc.

USPTO Granted Patents = 11

EPO Patents = 2

Trademarks = 7

Forward Citations = 9

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Leslie B Gordon (11 out of 14 patents)

Francis S Collins (11 out of 31 patents)

Adrienne Cox (4 out of 5 patents)

4. Thomas Glover (4 out of 4 patents)

5. Michael W Glynn (4 out of 6 patents)

6. Brian C Capell (4 out of 4 patents)

7. B Maria H Eriksson (4 out of 4 patents)

8. Channing J Der (4 out of 10 patents)

9. Kan Cao (3 out of 7 patents)

10. Michael R Erdos (3 out of 5 patents)

11. Ryszard M Kole (3 out of 29 patents)

12. W Ted Brown (3 out of 3 patents)

13. Richard Keith Bestwick (2 out of 36 patents)

14. William Ted Brown (1 out of 3 patents)

15. Adrienne D c/o Dept Radiation Oncology Cox (0 patent)

11 patents: Sort by Forward Citations

1. 11802283 - Oligonucleotide analogues targeting human LMNA (2023-10-31),

2. 10822608 - Oligonucleotide analogues targeting human LMNA (2020-11-03),

3. 10398721 - Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA (2019-09-03),

4. 9115400 - [object Object] (2015-08-25),

5. 8828356 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2014-09-09),

6. 8691501 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2014-04-08),

7. 8535884 - [object Object] (2013-09-17),

8. 8257915 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2012-09-04),

9. 8034557 - LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis (2011-10-11),

10. 7838531 - Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis (2010-11-23),

11. 7297492 - LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis (2007-11-20),

Progeria Research Foundation, Inc. (PRF) is a non-profit organization dedicated to finding a cure and treatment for Progeria, a rare and fatal genetic condition that causes rapid aging in children. PRF funds research, provides support to families, and raises awareness about Progeria.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#8 in Peabody, MA

#1,615 in Massachusetts

#26,743 in US

#50,237 in the World

Peabody, MA, United States of America

Progeria Research Foundation, Inc.

Forward Citations = 9

14 inventors:

Leslie B Gordon (11 out of 14 patents)

Francis S Collins (11 out of 31 patents)

Adrienne Cox (4 out of 5 patents)

4. Thomas Glover (4 out of 4 patents)

5. Michael W Glynn (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…